BE897536A - Medicament a action analgestique - Google Patents
Medicament a action analgestique Download PDFInfo
- Publication number
- BE897536A BE897536A BE0/211358A BE211358A BE897536A BE 897536 A BE897536 A BE 897536A BE 0/211358 A BE0/211358 A BE 0/211358A BE 211358 A BE211358 A BE 211358A BE 897536 A BE897536 A BE 897536A
- Authority
- BE
- Belgium
- Prior art keywords
- fatty acids
- content
- esters
- action
- analgesic action
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 13
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 5
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical class CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 claims description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical class CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 claims 1
- 150000001656 butanoic acid esters Chemical class 0.000 claims 1
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 239000000730 antalgic agent Substances 0.000 description 4
- 229940124641 pain reliever Drugs 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QOPBEBWGSGFROG-UHFFFAOYSA-N 2-(1h-indol-2-yl)acetic acid Chemical class C1=CC=C2NC(CC(=O)O)=CC2=C1 QOPBEBWGSGFROG-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027452 Metastases to bone Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- -1 hydroxy fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical compound C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- DNTVKOMHCDKATN-UHFFFAOYSA-N pyrazolidine-3,5-dione Chemical class O=C1CC(=O)NN1 DNTVKOMHCDKATN-UHFFFAOYSA-N 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823229955 DE3229955A1 (de) | 1982-08-12 | 1982-08-12 | Arzneimittel mit analgetischer wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE897536A true BE897536A (fr) | 1983-12-01 |
Family
ID=6170655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/211358A BE897536A (fr) | 1982-08-12 | 1983-08-12 | Medicament a action analgestique |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE897536A (OSRAM) |
| DE (1) | DE3229955A1 (OSRAM) |
| FR (1) | FR2531859A1 (OSRAM) |
| LU (1) | LU84952A1 (OSRAM) |
| NL (1) | NL8302830A (OSRAM) |
| SE (1) | SE8304331L (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8803141L (sv) * | 1988-09-07 | 1990-03-08 | Kabivitrum Ab | Naeringsmedel foer maenniskor och djur |
| GB0420856D0 (en) * | 2004-09-20 | 2004-10-20 | Ketocytonyx Inc | Cns modulators |
| EP1778615A4 (en) | 2004-07-20 | 2010-01-06 | Btg Int Ltd | OLIGOMERE KETONE COMPOUNDS |
-
1982
- 1982-08-12 DE DE19823229955 patent/DE3229955A1/de not_active Withdrawn
-
1983
- 1983-08-04 LU LU84952A patent/LU84952A1/de unknown
- 1983-08-09 SE SE8304331A patent/SE8304331L/ not_active Application Discontinuation
- 1983-08-11 NL NL8302830A patent/NL8302830A/nl not_active Application Discontinuation
- 1983-08-11 FR FR8313232A patent/FR2531859A1/fr active Granted
- 1983-08-12 BE BE0/211358A patent/BE897536A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2531859A1 (fr) | 1984-02-24 |
| SE8304331L (sv) | 1984-02-13 |
| DE3229955A1 (de) | 1984-02-16 |
| LU84952A1 (de) | 1983-12-28 |
| FR2531859B3 (OSRAM) | 1985-03-08 |
| NL8302830A (nl) | 1984-03-01 |
| SE8304331D0 (sv) | 1983-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013359392B2 (en) | Compositions and methods for tissue regeneration | |
| US20110065627A1 (en) | Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes | |
| EP0138931A1 (fr) | Composition dermatologique et son procede de preparation. | |
| EP0592569A1 (en) | Composition and method for transdermal delivery of diclofenac | |
| DE3205504A1 (de) | Aeusserlich anwendbares, ibuprofen enthaltendes arzneimittel | |
| EP0055635A1 (fr) | Composition pharmaceutique sous forme d'un gel contenant de l'acide acétylsalicylique | |
| BE1000381A4 (fr) | Preparation pharmaceutique a base d'indometacine. | |
| FR2692145A1 (fr) | Nouvelle composition à usage topique contenant de la diosmine. | |
| RU2470653C2 (ru) | Средство для лечения ожогов и ран | |
| BE897536A (fr) | Medicament a action analgestique | |
| WO2014176417A1 (en) | Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system | |
| FI100695B (fi) | Menetelmä valmistaa salisyylihappopitoinen aine hilseileviä ihosairauk sia vastaan | |
| FR2558058A1 (fr) | Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne | |
| WO1997019680A1 (fr) | Utilisation therapeutique d'agents betamimetiques pour traiter les douleurs menstruelles par voie permuqueuse | |
| WO1995008349A1 (en) | COMPOSITION CONTAINING OMEGA 3 AND/OR OMEGA 6 POLYUNSATURATED ACIDS HAVING FROM 12 to 22 CARBON ATOMS | |
| RU2142811C1 (ru) | Средство, обладающее противовоспалительным и репаративным действием | |
| WO2001003774A2 (en) | Pharmaceutical composition for the treatment of calcification | |
| JP3313894B2 (ja) | 経皮吸収促進剤及び皮膚外用剤 | |
| US20230255900A1 (en) | Compositions for topical treatment of radiation dermatitis | |
| JP3313893B2 (ja) | 経皮吸収促進剤及び皮膚外用剤 | |
| EP0865289B1 (fr) | Compositions a base d'arctium majus | |
| EP1526855A2 (fr) | Compositions pharmaceutiques destinees au traitement de l'incontinence urinaire | |
| JP3313892B2 (ja) | 経皮吸収促進剤及び皮膚外用剤 | |
| FR2566270A1 (fr) | Formes pharmaceutiques sous forme de gel, pour l'application topique de principes actifs | |
| CN101365464A (zh) | 一种环氧化合物的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: SCHULZE HEINRICH, ERICHSEN FRIEDRICH K., FISCHE Effective date: 19840812 |